GLP-1 drops: do they work and what to know?

24 Mar

GLP-1 drops have become one of the most searched terms in weight loss in 2025-2026. The promise? Same appetite suppressant effect as Ozempic and Wegovy, but without injections — just a few drops under the tongue. The problem is that the reality behind the marketing looks significantly different than what the product pages want to give the impression of. In this article, we review the scientific evidence for GLP-1 drops, compare them with injection-based alternatives and find out what is actually available on the Swedish market.

What are glp-1 drops and how are they different from injections?

GLP-1 drops are marketed as sublingual (under the tongue) or oral formulations that contain either synthetic GLP-1 receptor agonists or natural ingredients that are claimed to stimulate the body’s own GLP-1 production. The difference between these two categories is huge and completely determines whether the product has any chance of working.

The first category — synthetic GLP-1 agonists in drop form — includes experimental formulations of semaglutide and similar peptides. These are in early research phases and are not yet available as approved medicines. The challenge is bioavailability: peptides like semaglutide are quickly broken down by enzymes in the oral cavity and gastrointestinal tract. The injection form completely bypasses this problem by delivering the substance directly into the bloodstream.

The second category — “natural GLP-1 boosters” — often consists of plant extracts, amino acids or prebiotic fibers that are claimed to increase the body’s own GLP-1 secretion. Yerba mate, berberine and inulin are common ingredients. While some of these have shown modest effects on GLP-1 levels in laboratory studies, the magnitude is not comparable to pharmacological doses of semaglutide.

How are glp-1 drops taken and what dose is required?

Most products instruct the user to take 1–2 ml under the tongue, 15–30 minutes before meals, 2–3 times per day. Sublingual absorption sounds promising in theory — the mucosa under the tongue has a rich blood supply and can absorb certain molecules directly. Nitroglycerin and some B vitamins work great sublingually.

However, peptides such as semaglutide are too large and too unstable for effective sublingual absorption without advanced formulation techniques (eg permeation enhancers or nanoparticles). Semaglutide has a molecular weight of about 4,100 daltons — well above the limit of what normally passes through the oral mucosa unaided. The drop products sold online lack this technology in the vast majority of cases. The dose that actually reaches the bloodstream may be a fraction of what is stated on the label — if the substance is even there.

Is there scientific evidence behind glp-1 drops?

The answer in short: not in the form of randomized controlled trials with sublingual GLP-1 drops that are now sold commercially. The research that does exist concerns oral semaglutide in tablet form (Rybelsus), which is a completely different drug with a specific formulation designed to survive stomach acid.

The table below compares the different routes of administration of semaglutide and what is actually proven in clinical studies (2020-2025):

|Administration path|Product|Bioavailability|Clinical evidence|Approved in Sweden?|

|Subcutaneous injection|Ozempic/Wegovy| ~89 % |STEP 1–5, thousands of participants|Yes|

|Oral tablet|Rybelsus (14 mg)| ~0,4–1 % |PIONEER 1-10, thousands of participants|Yes|

|Sublingual drops|Various brands|Unknown (not tested)|No published RCTs|No (no medicine)|

The contrast is striking. Even the oral tablet Rybelsus has extremely low bioavailability — less than 1% of the substance reaches the bloodstream — and requires a special formulation with the absorption enhancer SNAC (sodium salcaprozate) to work at all. Despite this sophisticated technology, the tablet must be taken on an empty stomach with a maximum of 120 ml of water, and the patient must wait at least 30 minutes before eating or drinking. GLP-1 drops without this type of formulation are even less likely to deliver a pharmacologically active dose.

There is a complete lack of published studies specifically evaluating sublingual GLP-1 drops for weight loss in humans. The studies manufacturers refer to are either about individual ingredients (berberine, yerba mate) in other forms of administration, or about GLP-1 as a hormone in general — not about their specific drop products.

Berberine deserves a comment in this context. In several studies, the substance has shown a modest effect on blood sugar control and can indirectly affect GLP-1 secretion. But the effect size is small compared to semaglutide — a 2023 meta-analysis found that berberine lowers HbA1c by about 0.5 percentage points, compared to semaglutide’s 1.0–1.5 percentage points. Marketing berberine drops as “natural Ozempic” is therefore grossly misleading, even though berberine itself may have some benefit as a supplement to dietary changes.

Can you buy glp-1 drops in Sweden — and should you?

Technically, you can order GLP-1 drops online from Swedish and international webshops. The products are usually classified as food supplements, not as medicines, which means that they have not been reviewed by the Swedish Medicines Agency. This legal classification is also the reason why they can be sold freely — but it also means that no requirements are placed on clinical efficacy documentation.

Here are warning flags to look for before buying weight loss drops online:

• The product mentions “semaglutide” or “GLP-1 agonist” as an ingredient without being an approved drug — this may indicate either false marketing or the illegal sale of prescription substances.

• The manufacturer refers to studies that are not about their specific product, but about GLP-1 in general or about individual ingredients in completely different doses and formulations.

• Unreasonable promises like “lose 10 kg in a month” or “same effect as Ozempic without injection” — no serious manufacturer can back such claims with data.

• Lack of third-party analysis or certification — without independent testing, you don’t know what the bottle actually contains.

• Prices that seem too good to be true — if a product costs a tenth of Ozempic but claims to deliver the same results, you should question why.

Do you want to know which GLP-1 alternatives are actually available without a prescription in Sweden? Read our review of over-the-counter GLP-1 alternatives for a complete overview.

Alternatives to glp-1 drops that actually have evidence

If you are attracted to GLP-1 drops because you want to avoid injections, there are approved alternatives that have actually undergone clinical trials. Rybelsus (oral semaglutide) is the closest you will get to an “injection-free” GLP-1 treatment with documented efficacy. The tablet requires a prescription and costs about the same as Ozempic (around SEK 1,500–2,500 per month in Sweden in 2026), but eliminates the need for needles completely.

Why is the injection form superior to semaglutide?

Subcutaneous injection delivers semaglutide directly under the skin, from where it is absorbed slowly and evenly over a full week. Bioavailability is around 89%, which means that almost all of the substance reaches the bloodstream. Compare this to Rybelsus oral tablet (below 1%) or sublingual drops (unknown, but likely even lower). The injection thus provides maximum effect per milligram of substance.

It’s also worth pointing out that the injectable form only requires one dose per week, while most GLP-1 drops should be taken 2-3 times daily. Thus, the actual convenience of drops is not necessarily higher — seven dosing sessions per week versus one.

Modern pre-filled pens such as the Ozempic FlexTouch have thin needles (31G) that most users describe as almost painless. The fear of needles is understandable but rarely justified after the first injection — the vast majority get used to it within 2-3 weeks. Our complete guide to semaglutide covers everything from injection technique to dose escalation.

In summary: GLP-1 drops in their current form lack the scientific basis necessary to recommend them. Anyone who wants to benefit from the GLP-1 mechanism for weight loss should currently choose between approved injections or the oral tablet Rybelsus — both with thousands of patients and many years of solid clinical data behind them.

.entry-content